Staar Surgical (STAA) Cash & Current Investments (2016 - 2026)
Staar Surgical's Cash & Current Investments history spans 17 years, with the latest figure at $187.5 million for Q1 2026.
- For Q1 2026, Cash & Current Investments fell 18.64% year-over-year to $187.5 million; the TTM value through Jan 2026 reached $187.5 million, down 18.64%, while the annual FY2026 figure was $187.5 million, 18.64% down from the prior year.
- Cash & Current Investments reached $187.5 million in Q1 2026 per STAA's latest filing, down from $192.7 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $245.1 million in Q1 2024 to a low of $187.5 million in Q1 2026.
- Average Cash & Current Investments over 5 years is $210.2 million, with a median of $207.6 million recorded in 2022.
- Peak YoY movement for Cash & Current Investments: grew 25.43% in 2024, then dropped 19.27% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $211.6 million in 2022, then grew by 4.29% to $220.7 million in 2023, then grew by 4.43% to $230.5 million in 2024, then fell by 16.41% to $192.7 million in 2025, then decreased by 2.66% to $187.5 million in 2026.
- Per Business Quant, the three most recent readings for STAA's Cash & Current Investments are $187.5 million (Q1 2026), $192.7 million (Q3 2025), and $189.9 million (Q2 2025).